8-K/A

BIOTIME 8-K/A 5-3-2010

Company: Lineage Cell Therapeutics, Inc.
Filed: July 16, 2010
Period of Report: May 3, 2010
Accession Number: 0001140361-10-029564

View Document ↗ View on SEC.gov ↗